AdvaMed Launches National Search For New CEO As Ubl Plans Departure

AdvaMed CEO Steve Ubl is leaving the device trade association to take the helm of the Pharmaceutical Research and Manufacturers of America. Ubl has led AdvaMed for 10 years, raising the profile of the device industry among policymakers, fighting perception battles and, of course, opposing the device tax.

More from Regulation

More from Policy & Regulation